{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "DecreaseAmount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02312",
      "entity_text" : "9p21 locus",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1092" ],
      "Cellular_component" : [ "go:GO:0005694" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Promising candidates have included NMP22 (nuclear matrix protein-22, expression of which reflects mitotic activity), UroVysion (detects aneuploidy for chromosomes 3, 7, 17, and the loss of 9p21 locus (tumour suppressor) using fluorescence in situ hybridization) and ImmunocCyst (uses fluorescence labelled antibodies to exfoliated antigens from BC cells), but none have gained widespread uptake owing to the wide sensitivity and specificity ranges [30-100% (EAU)].",
  "reading_complete" : "2020-08-04T10:56:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:54:10Z",
  "trigger" : "loss",
  "evidence" : [ "loss of 9p21 locus" ],
  "pmc_id" : "6414346",
  "score" : 0
}